POL open access to health products
K |
|||
| Zeile 7: | Zeile 7: | ||
{{tp|p=32498725|t=2020. Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons.|pdf=|usr=017}} | {{tp|p=32498725|t=2020. Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons.|pdf=|usr=017}} | ||
{{tp|p=32724145|t=2020. COVID-19: save lives with open intellectual-property licences.|pdf=|usr=017}} | {{tp|p=32724145|t=2020. COVID-19: save lives with open intellectual-property licences.|pdf=|usr=017}} | ||
| + | {{tp|p=32815509|t=2020. Impact of the COVID-19 Pandemic on Consumers' Access to Essential Medicines in Nigeria.|pdf=|usr=019}} | ||
| + | {{tp|p=32816716|t=2020. Covid-19: Pre-purchasing vaccine-sensible or selfish?|pdf=|usr=018}} | ||
| + | {{tp|p=32836868|t=2020. Moral Suasion and the Private Provision of Public Goods: Evidence from the COVID-19 Pandemic.|pdf=|usr=019}} | ||
Version vom 16. Dezember 2020, 20:45 Uhr
32382151 2020. Protect against market exclusivity in the fight against COVID-19.
32366506 2020. Covid-19: Doctors face shortages of vital drugs, gases, and therapeutics, survey finds.
32433624 2020. Coronavirus: everyone wins when patents are pooled.
32449007 2020. In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs.
32452010 2020. Financing Drug Innovation in the US: Current Framework and Emerging Challenges.
32467411 2020. On Patient Safety: COVID-19 Exposes the Dangerous State of Drug and Device Supply Chains.
32498725 2020. Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons.
32724145 2020. COVID-19: save lives with open intellectual-property licences.
32815509 2020. Impact of the COVID-19 Pandemic on Consumers' Access to Essential Medicines in Nigeria.
32816716 2020. Covid-19: Pre-purchasing vaccine-sensible or selfish?
32836868 2020. Moral Suasion and the Private Provision of Public Goods: Evidence from the COVID-19 Pandemic.
